Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


31.07.2017

1 Anticancer Res
1 Biomed Pharmacother
2 BJU Int
1 Braz J Med Biol Res
2 Cancer
1 Cancer Res
1 Cell Cycle
2 Eur Rev Med Pharmacol Sci
1 Expert Opin Biol Ther
1 Int J Clin Oncol
1 Int J Radiat Oncol Biol Phys
3 Int J Urol
1 Int Urol Nephrol
1 J Cancer Res Clin Oncol
1 J Med Chem
1 Med Clin (Barc)
1 Nan Fang Yi Ke Da Xue Xue Bao
1 Nat Commun
2 Oncotarget
1 Pathol Oncol Res
1 Pharmacogenomics
1 Sichuan Da Xue Xue Bao Yi Xue Ban
1 Toxicol In Vitro
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. TANG X, Wang S, An C, DU P, et al
    Preoperative High Neutrophil-to-Lymphocyte Ratio Is Associated with High-grade Bladder Cancer.
    Anticancer Res. 2017;37:4659-4663.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  2. TESSMANN JW, Buss J, Begnini KR, Berneira LM, et al
    Antitumor potential of 1-thiocarbamoyl-3,5-diaryl-4,5-dihydro-1H-pyrazoles in human bladder cancer cells.
    Biomed Pharmacother. 2017;94:37-46.
    PubMed     Text format     Abstract available


    BJU Int

  3. WAINGANKAR N, Mallin K, Smaldone M, Egleston BL, et al
    Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy.
    BJU Int. 2017;120:239-245.
    PubMed     Text format     Abstract available

  4. MILLER C, Campain NJ, Dbeis R, Daugherty M, et al
    Introduction of robot-assisted radical cystectomy within an established enhanced recovery programme.
    BJU Int. 2017;120:265-272.
    PubMed     Text format     Abstract available


    Braz J Med Biol Res

  5. CAO JY, Yin HS, Li HS, Yu XQ, et al
    Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells.
    Braz J Med Biol Res. 2017;50:e6207.
    PubMed     Text format     Abstract available


    Cancer

  6. CAHN DB, Handorf EA, Ghiraldi EM, Ristau BT, et al
    Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30900.
    PubMed     Text format     Abstract available

  7. VETTERLEIN MW, Wankowicz SAM, Seisen T, Lander R, et al
    Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30907.
    PubMed     Text format     Abstract available


    Cancer Res

  8. MIAO L, Liu Q, Lin CM, Luo C, et al
    Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
    Cancer Res. 2017;77:719-731.
    PubMed     Text format     Abstract available


    Cell Cycle

  9. WEN W, Li J, Wang L, Xing Y, et al
    Inhibition of NEDD4 inhibits cell growth and invasion and induces cell apoptosis in bladder cancer cells.
    Cell Cycle. 2017 Jul 26:1-6. doi: 10.1080/15384101.2017.1338220.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  10. LI MZ, Lai DH, Zhao HB, Chen Z, et al
    SOCS3 overexpression enhances ADM resistance in bladder cancer T24 cells.
    Eur Rev Med Pharmacol Sci. 2017;21:3005-3011.
    PubMed     Text format     Abstract available

  11. PAN ZJ, Deng N, Zou ZH, Chen GX, et al
    The effect of curcumin on bladder tumor in rat model.
    Eur Rev Med Pharmacol Sci. 2017;21:884-889.
    PubMed     Text format     Abstract available


    Expert Opin Biol Ther

  12. HAKENBERG OW
    Nivolumab for the treatment of bladder cancer.
    Expert Opin Biol Ther. 2017 Jul 24:1-7. doi: 10.1080/14712598.2017.1353076.
    PubMed     Text format     Abstract available


    Int J Clin Oncol

  13. TANG X, Du P, Yang Y
    The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.
    Int J Clin Oncol. 2017 Jul 27. doi: 10.1007/s10147-017-1171.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  14. CHARGARI C, Haie-Meder C, Guerin F, Minard-Colin V, et al
    Brachytherapy Combined With Surgery for Conservative Treatment of Children With Bladder Neck and/or Prostate Rhabdomyosarcoma.
    Int J Radiat Oncol Biol Phys. 2017;98:352-359.
    PubMed     Text format     Abstract available


    Int J Urol

  15. SALUJA M, Gilling P
    Intravesical bacillus Calmette-Guerin instillation in non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Jul 25. doi: 10.1111/iju.13410.
    PubMed     Text format     Abstract available

  16. KOBATAKE K, Hayashi T, Black PC, Goto K, et al
    Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 22. doi: 10.1111/iju.13389.
    PubMed     Text format     Abstract available

  17. NASELLI A
    Editorial Comment to Chronic kidney disease as a risk factor for recurrence and progression in patients with primary non-muscle-invasive bladder cancer.
    Int J Urol. 2017 Jul 21. doi: 10.1111/iju.13402.
    PubMed     Text format    


    Int Urol Nephrol

  18. MAHMOUD O, El-Assmy A, Kamal M, Ashamallah A, et al
    Is chronic alkali therapy in orthotopic ileal neobladders necessary? A prospective controlled study.
    Int Urol Nephrol. 2017;49:49-53.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  19. HE X, Hou J, Ping J, Wen D, et al
    Opa interacting protein 5 acts as an oncogene in bladder cancer.
    J Cancer Res Clin Oncol. 2017 Jul 27. doi: 10.1007/s00432-017-2485.
    PubMed     Text format     Abstract available


    J Med Chem

  20. ZHANG GH, Yuan JM, Qian G, Gu CX, et al
    Phthalazino[1,2-b]quinazolinones as p53 Activators: Cell Cycle Arrest, Apoptotic Response and Bak-Bcl-xl Complex Reorganization in Bladder Cancer Cells.
    J Med Chem. 2017 Jul 26. doi: 10.1021/acs.jmedchem.6b01769.
    PubMed     Text format     Abstract available


    Med Clin (Barc)

  21. MARTINEZ RODRIGUEZ RH, Buisan Rueda O, Ibarz L
    Bladder cancer: Present and future.
    Med Clin (Barc). 2017 Jul 20. pii: S0025-7753(17)30478.
    PubMed     Text format     Abstract available


    Nan Fang Yi Ke Da Xue Xue Bao

  22. WANG CY, Nie QW, Zhou X, Huang DX, et al
    [S100A4, a potential therapeutic target on bladder cancer stem cells].
    Nan Fang Yi Ke Da Xue Xue Bao. 2017;37:869-874.
    PubMed     Text format     Abstract available


    Nat Commun

  23. KORPAL M, Puyang X, Jeremy Wu Z, Seiler R, et al
    Evasion of immunosurveillance by genomic alterations of PPARgamma/RXRalpha in bladder cancer.
    Nat Commun. 2017;8:103.
    PubMed     Text format     Abstract available


    Oncotarget

  24. WANG X, Cui MM, Xu Y, Liu L, et al
    Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer.
    Oncotarget. 2017 Jul 12. doi: 10.18632/oncotarget.19242.
    PubMed     Text format     Abstract available

  25. LI H, Xu Y, Li H
    CD147 as a novel biomarker for predicting the prognosis and clinicopathological features of bladder cancer: a meta-analysis.
    Oncotarget. 2017 Jul 15. doi: 10.18632/oncotarget.19257.
    PubMed     Text format     Abstract available


    Pathol Oncol Res

  26. DZOMBETA T, Kruslin B
    High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.
    Pathol Oncol Res. 2017 Jul 27. doi: 10.1007/s12253-017-0279.
    PubMed     Text format     Abstract available


    Pharmacogenomics

  27. ZUIVERLOON TC, Theodorescu D
    Pharmacogenomic considerations in the treatment of muscle-invasive bladder cancer.
    Pharmacogenomics. 2017 Jul 26. doi: 10.2217/pgs-2017-0055.
    PubMed     Text format     Abstract available


    Sichuan Da Xue Xue Bao Yi Xue Ban

  28. YANG YB, Bai YJ, Tang Y, Liu ZH, et al
    [Detection of Circulating Tumor Cells in Bladder Cancer by Subtraction Enrichment and Immunostaining-fluorescence in situ Hybridization].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2017;48:605-609.
    PubMed     Text format     Abstract available


    Toxicol In Vitro

  29. WEWERING F, Jouy F, Caliskan S, Kalkhof S, et al
    Hepatic co-cultures in vitro reveal suitable to detect Nrf2-mediated oxidative stress responses on the bladder carcinogen o-anisidine.
    Toxicol In Vitro. 2017;40:153-160.
    PubMed     Text format     Abstract available


    Urology

  30. KOO K, Zubkoff L, Sirovich BE, Goodney PP, et al
    The Burden of Cystoscopic Bladder Cancer Surveillance: Anxiety, Discomfort, and Patient Preferences for Decision Making.
    Urology. 2017 Jul 21. pii: S0090-4295(17)30754.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: